Oct 2026· Bioscience Reports· Vol 46· 0 citations· 90 references
Medicine
TL;DR
This review summarizes current knowledge of MUC17 biology, from genomic organization and protein architecture to glycosylation, trafficking, developmental regulation, and barrier function, and places particular emphasis on how MUC17 contributes to size-selective exclusion, bacterial segregation, and host-microbe homeostasis.
Abstract
Abstract The intestinal epithelial surface is protected by a multilayered barrier system that includes secreted mucus and a membrane-bound glycocalyx. While gel-forming mucins have been extensively studied, the transmembrane mucins that form the enterocyte glycocalyx remain less well understood. MUC17 has emerged as a dominant and functionally important transmembrane mucin of the small intestinal brush border, where its large, extensively O-glycosylated extracellular domain forms a dense, hydrated barrier between luminal microbes and the epithelial membrane. This review summarizes current knowledge of MUC17 biology, from genomic organization and protein architecture to glycosylation, trafficking, developmental regulation, and barrier function. Particular emphasis is placed on how MUC17 contributes to size-selective exclusion, bacterial segregation, and host-microbe homeostasis. This review further discusses the developmental establishment of the MUC17-rich enterocyte glycocalyx during the suckling–weaning transition and covers the mechanisms that regulate MUC17 localization and dynamics in epithelial cells, including apical targeting, membrane retention, recycling, turnover, and responses to inflammatory cues. Finally, the review examines the consequences of altered MUC17 expression or function, with particular emphasis on glycocalyx barrier defects, host-microbe interactions, bacterial access to the epithelium, and the relevance of MUC17 dysfunction to Crohn’s disease and experimental models of intestinal infection. Together, the review positions MUC17 as a central structural and functional component of the intestinal glycocalyx and an underexplored therapeutic axis for restoring epithelial barrier integrity in intestinal disease.
The intestinal barrier separates the luminal content, including the gut microbiota, dietary antigens and toxins, from the mucosal immune system, and its integrity is essential for immune homeostasis. Loss of barrier control, commonly termed increased intestinal permeability or leaky gut, has been implicated in a broad...
David Granizo-Bermejo, Guillermo García-Pérez-de-Sevilla, Antonio Molina-López· Frontiers in Nutrition· 0 citations
This review systematically proposes a conceptual framework for the “reprogramming of the intestinal mucosal barrier microenvironment by S-palmitoylation” to provide novel molecular targets and a theoretical foundation for the development of mucosal healing therapies that are independent of traditional immunosuppression...
Yan-Jie Chen, Jin-Yin Xiao, Hui-Yuan Liu et al.· Frontiers in Pharmacology· 0 citations
Akkermansia muciniphila is a next-generation probiotic linked to intestinal barrier integrity and host metabolic well-being. However, the mechanisms underlying its mucin utilization remain incompletely understood. In particular, the temporal hierarchy of enzyme deployment, the subcellular and extracellular-vesicle loca...
Hassan Alarjani, Nawaf S. Alsulami, Hanan A. Alshamrani et al.· Molecules· 0 citations
The mechanisms underlying the health benefits of probiotics remain incompletely understood. Among the proposed mediators, bacterial extracellular vesicles (EVs) have been proposed as mediators of interkingdom communication between probiotic bacteria and their hosts. In this study, we show that Lacticaseibacillus casei...
A. P. Domínguez Rubio, C. Antoni, M. N. García et al.· Molecular Nutrition & Food R...· 0 citations
Despite the variety of hosts, anatomical locations, and symptoms associated with infection, many bacteria have developed mechanisms that allow them to adhere to the cells via carbohydrates. Some of the most dangerous bacterial pathogens including Clostridium perfringens possess sialidases that are capable of removing s...
E. Abuhussein, Dhirendra K. Singh, Yukihiro Yamaguchi et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.